Meet the Scientists Still in the Running for Congressional Seats

After a surge of political enthusiasm among the scientific community since 2016, only a small fraction of candidates with science and engineering backgrounds made it through primary elections this year.

Written byKatarina Zimmer
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: Randy Wadkins, a biochemist at the University of Mississippi, is running as a Democrat for Congress.
TENOLA PLAXICO

In 2018, an unprecedented number of individuals across the country with science and technical backgrounds made a run for Congress. Many of them were energized by the perceived anti-science rhetoric of President Donald Trump and his administration concerning the environment and health, and by a desire to bring more evidence-based decision making into politics. Although a handful of candidates have advanced to next month’s midterm election, many didn’t make it through the primaries.

Of nearly 50 individuals with a science, technology, engineering, or math (STEM) background—all of them Democrats—who sought a House seat this year and were tracked by Science, 30 were knocked out during their states’ primaries. 314 Action, a Washington DC–based nonprofit leading an organized effort to elect more scientists and engineers into public office, has also seen some attrition: ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • katya katarina zimmer

    After a year teaching an algorithm to differentiate between the echolocation calls of different bat species, Katarina decided she was simply too greedy to focus on one field of science and wanted to write about all of them. Following an internship with The Scientist in 2017, she’s been happily freelancing for a number of publications, covering everything from climate change to oncology. Katarina is a news correspondent for The Scientist and contributes occasional features to the magazine. Find her on Twitter @katarinazimmer and read her work on her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies